These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34619099)

  • 1. Navigating from SARS-CoV-2 elimination to endemicity in Australia, Hong Kong, New Zealand, and Singapore.
    De Foo C; Grépin KA; Cook AR; Hsu LY; Bartos M; Singh S; Asgari N; Teo YY; Heymann DL; Legido-Quigley H
    Lancet; 2021 Oct; 398(10311):1547-1551. PubMed ID: 34619099
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 primary care response and challenges in Singapore: a tale of two curves.
    Liow Y; Loh VWK; Goh LH; Tan DHY; Tan TL; Leong CK; Young DYL
    Hong Kong Med J; 2021 Feb; 27(1):70-72. PubMed ID: 33558446
    [No Abstract]   [Full Text] [Related]  

  • 3. Personal protective equipment preparedness in Asia-Pacific intensive care units during the coronavirus disease 2019 pandemic: A multinational survey.
    Rajamani A; Subramaniam A; Shekar K; Haji J; Luo J; Bihari S; Wong WT; Gullapalli N; Renner M; Alcancia CM; Ramanathan K;
    Aust Crit Care; 2021 Mar; 34(2):135-141. PubMed ID: 33214027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with COVID-19 vaccination intent in Singapore, Australia and Hong Kong.
    Shah S; Gui H; Chua PEY; Tan JB; Suen LK; Chan SW; Pang J
    Vaccine; 2022 May; 40(21):2949-2959. PubMed ID: 35414417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine hesitancy and COVID-19 vaccination in Hong Kong.
    Chan PKS; Wong MCS; Wong ELY
    Hong Kong Med J; 2021 Apr; 27(2):90-91. PubMed ID: 33879624
    [No Abstract]   [Full Text] [Related]  

  • 6. Emergence of SARS-CoV-2 lineage B.1.617.2 in the local community of Hong Kong.
    Tsang AKL; Mak GCK; Leung PKL; Cheng PKC; Yip PCW; Lam ETK; Ng KHL; Chan RCW
    J Med Virol; 2022 Jan; 94(1):29-31. PubMed ID: 34499356
    [No Abstract]   [Full Text] [Related]  

  • 7. Mitigation policies, community mobility, and COVID-19 case counts in Australia, Japan, Hong Kong, and Singapore.
    Hakim AJ; Victory KR; Chevinsky JR; Hast MA; Weikum D; Kazazian L; Mirza S; Bhatkoti R; Schmitz MM; Lynch M; Marston BJ
    Public Health; 2021 May; 194():238-244. PubMed ID: 33965795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Audio Interview: An International Look at Covid-19.
    Rubin EJ; Baden LR; Nottage K; O'Connell J; Wong G; Morrissey S
    N Engl J Med; 2021 Jan; 384(3):e19. PubMed ID: 33471986
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 control and preventive measures: a medico-legal analysis.
    Li VWT; Wan TTW
    Hong Kong Med J; 2021 Jun; 27(1):224-225. PubMed ID: 34127560
    [No Abstract]   [Full Text] [Related]  

  • 10. Impacts of the COVID-19 pandemic on the physical and mental health of children.
    Tse WWY; Kwan MYW
    Hong Kong Med J; 2021 Jun; 27(1):175-176. PubMed ID: 34413251
    [No Abstract]   [Full Text] [Related]  

  • 11. Public acceptability of COVID-19 control measures in Singapore, Hong Kong, and Malaysia: A cross-sectional survey.
    Voo TC; Ballantyne A; Ng CJ; Cowling BJ; Xiao J; Phang KC; Kaur S; Jenarun G; Kumar V; Lim JM; Tun ZM; Wong NCB; Tam CC
    Int J Infect Dis; 2022 Jul; 120():51-58. PubMed ID: 35430376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The shift of percent excess mortality from zero-COVID policy to living-with-COVID policy in Singapore, South Korea, Australia, New Zealand and Hong Kong SAR.
    Cao X; Li Y; Zi Y; Zhu Y
    Front Public Health; 2023; 11():1085451. PubMed ID: 37020822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One year into COVID-19 pandemic, what do we have to look forward to?
    Hung IFN
    Hong Kong Med J; 2021 Apr; 27(2):92-94. PubMed ID: 33879625
    [No Abstract]   [Full Text] [Related]  

  • 14. Using the Systems Engineering Initiative for Patient Safety (SEIPS) model to describe the planning and management of the COVID-19 pandemic in Hong Kong.
    Kwan WM; Mok CK; Kwok YT; Ling H; Lam HW; Law TH; Leung PM; Mak MY; Que TL; Kan CH; Tang YH
    Int J Qual Health Care; 2021 Mar; 33(1):. PubMed ID: 33682006
    [No Abstract]   [Full Text] [Related]  

  • 15. Certifying Guinea worm eradication: current challenges.
    Molyneux DH; Eberhard ML; Cleaveland S; Addey R; Guiguemdé RT; Kumar A; Magnussen P; Breman JG
    Lancet; 2020 Dec; 396(10265):1857-1860. PubMed ID: 33278938
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful Elimination of Covid-19 Transmission in New Zealand.
    Baker MG; Wilson N; Anglemyer A
    N Engl J Med; 2020 Aug; 383(8):e56. PubMed ID: 32767891
    [No Abstract]   [Full Text] [Related]  

  • 17. Using Societal Values to Inform Public Health Policy During the COVID-19 Pandemic: The Role of Health Preference Research.
    DiSantostefano RL; Terris-Prestholt F
    Patient; 2021 May; 14(3):303-307. PubMed ID: 33886102
    [No Abstract]   [Full Text] [Related]  

  • 18. The guiding principles for populational COVID-19 vaccine selection: A normative analysis through comparison of the strategies in Hong Kong and Singapore.
    Chan TK
    J Glob Health; 2022; 12():03004. PubMed ID: 35265324
    [No Abstract]   [Full Text] [Related]  

  • 19. From a Sprint to a Marathon in Hong Kong.
    Leung GM; Cowling BJ; Wu JT
    N Engl J Med; 2020 Apr; 382(18):e45. PubMed ID: 32294373
    [No Abstract]   [Full Text] [Related]  

  • 20. Importance of sustaining non-pharmaceutical interventions for COVID-19 until herd immunity.
    Huang J; Xu W; Zheng Z; Wong MCS
    Hong Kong Med J; 2021 Apr; 27(2):95-96. PubMed ID: 33879626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.